Evolving Management Strategies for Metastatic Esophageal and Gastroesophageal Junction Adenocarcinoma

Metastatic or unresectable esophageal and gastroesophageal junction adenocarcinoma represent a devastating disease with 5-year survival rate of <5%. Although cytotoxic chemotherapy with platinum-doublet-based regimens is initially effective, patients inevitably progress. Patients often decline ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Satya, Gibson, Michael K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527138/
https://www.ncbi.nlm.nih.gov/pubmed/31119034
http://dx.doi.org/10.17925/OHR.2018.14.2.82

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527138/
https://www.ncbi.nlm.nih.gov/pubmed/31119034
http://dx.doi.org/10.17925/OHR.2018.14.2.82

Ejemplares similares